Urinary Disorders in Patients With Multiple Sclerosis: Invasive Vs Non-invasive Investigations.
NCT ID: NCT03336424
Last Updated: 2018-09-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2017-10-01
2019-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bladder Management in Patients With Multiple Sclerosis: Optimizing Practice Patterns
NCT01930799
Remote Evaluation in Patients With Multiple Sclerosis
NCT06308042
Cortical Inhibition in Patients With Multiple Sclerosis
NCT07128160
Coaching and Activity Tracking in Multiple Sclerosis - A Pilot Study
NCT03335618
Validation of Multimodal Evoked Potentials (mmEP) for Predicting Disease Progression in Multiple Sclerosis
NCT03632473
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
An evaluation will be made one month, 3 months and 6 months after the first visit.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Non-invasive investigations group
Non-invasive investigations include: ultrasound, blood exam, urine analysis and culture, uroflowmetry
Non-invasive investigations
Ultrasound, blood tests, urine analysis and culture, uroflowmetry
Invasive investigations group
urodynamic study including: cystomanometry, pressure flow study, EMG
Non-invasive investigations
Ultrasound, blood tests, urine analysis and culture, uroflowmetry
Invasive investigations
Cystomanometry, pressure flow study, EMG
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Non-invasive investigations
Ultrasound, blood tests, urine analysis and culture, uroflowmetry
Invasive investigations
Cystomanometry, pressure flow study, EMG
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Bladder cancer
* prostate cancer
* urethral stenosis
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Saint-Joseph University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elie EL HELOU, MD
Role: PRINCIPAL_INVESTIGATOR
Saint-Joseph University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Saint Joseph University
Beirut, , Lebanon
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FM292
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.